No Detail Found!

Comparison of intracoronary and intravenous administration of high dose bolus tirofiban in patients of St elevation myocardial infarction undergoing primary percutaneous coronary intervention

Author(s)
Muhamad Abbas Khan Department of Interventional Cardiology Hayatabad Medical Complex, Peshawar, Pakistan
Muhammad Salman Department of Interventional Cardiology Hayatabad Medical Complex, Peshawar, Pakistan
Saleem Ullah Department of Interventional Cardiology, National Institute of Cardiovascular Diseases, Karachi, Pakistan
Mahmood Ul Hassan Department of Interventional Cardiology Hayatabad Medical Complex, Peshawar, Pakistan
Muhammad Abdul Wahab Hayatabad Medical Complex, Peshawar, Pakistan
Hamid Ali Shah Department of Interventional Cardiology Hayatabad Medical Complex, Peshawar, Pakistan
Abstract
Acute ST-elevation myocardial infarction (STEMI) is a condition in which transmural myocardial ischemia causes myocardial necrosis and is the leading cause of death. Objectives: To compare the efficacy of tirofiban bolus administration via percutaneous coronary intervention (PCI) and intravenous route (IV) in STEMI patients for restoration of myocardial perfusion. Methods: A retrospective cross-sectional study was conducted at Cardiology Department, Hayatabad Medical Complex, Peshawar, during 2021-22. The study comprised 168 STEMI patients divided into Group A and B (n=84), treated with tiro??ban PCI and IV route, respectively. Results: Incidence of STEMI was three folds higher in males than females, and the mean age of the patients was 55 years. Smoking and obesity were the potential risk factors. Patients in Group A had a better clinical outcome and prognosis than Group B. In comparison to the IV treatment group (91.66%), the ST-segment resolution time was considerably lower (P<0.05) in the PCI group (48.80%). In both groups, the observational parameters for TIMI flow grade, TIMI major and minor bleeding, MBG, and MACE were not-significantly different (P=0.05), comprising percentages 94, 3.57, 9.52, 71.42, 5.95%, and 84.52, 2.38, 13.09, 75, 15.47%, respectively. In comparison to IV therapy group, the LVEF percentage in PCI group was statistically significant (P<0.05) after 24 hours and 30 days (57, 63 and 52, 58%, respectively). Conclusions: It was concluded that STEMI patients treated with PCI tirofiban bolus had significantly greater (p<0.05) recovery rates, left ventricular ejection fractions and better clinical outcomes than IV-treated group.
Publication Details
Page(s) 185-189
Published Journal: Pakistan Journal of Health Sciences, Volume: 3, Issue: 7, Year: 2022

Request the full text from PASTIC

Keywords
Myocardial Infarction, Hypertension, Coronary Intervention, Tirofiban bolus
0

Citations

0

Downloads

119

Views